endocrinology
Bone health

Sclerostin inhibition promising in osteoporosis

Genetic abnormalities in 30 people in a Dutch fishing village and about a hundred South African Afrikaners have provided the clues needed to develop sclerostin inhibitors as a potential new treatment for osteoporosis. Professor Socrates Papapoulos, from the Leiden University Medical Center in The Netherlands, described the progressive bone overgrowth that occurred during the first ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic